SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines

<p dir="ltr">Neutralizing antibodies (NAbs) are elicited after infection and vaccination and have been well studied. However, their antibody‐dependent cellular cytotoxicity (ADCC) functionality is still poorly characterized. Here, we investigated ADCC activity in convalescent sera fr...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Hadeel T. Zedan (12535521) (author)
مؤلفون آخرون:	Maria K. Smatti (4675852) (author), Duaa W. Al‐Sadeq (22045124) (author), Hebah A. Al Khatib (10494573) (author), Eleonora Nicolai (496034) (author), Massimo Pieri (5023022) (author), Sergio Bernardini (504056) (author), Ali Ait Hssain (11264358) (author), Sara Taleb (11264352) (author), Hamda Qotba (12794976) (author), Khodr Issa (18174916) (author), Laith J. Abu Raddad (16931811) (author), Asmaa A. Althani (4675855) (author), Gheyath K. Nasrallah (9200525) (author), Hadi M. Yassine (4675846) (author)
منشور في:	2024
الموضوعات:	Biomedical and clinical sciences Clinical sciences Immunology Health sciences Public health ADCC COVID‐19 COVID‐19 vaccines humoral responses neutralizing antibodies NK cells SARS‐CoV‐2
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines

مواد مشابهة